0 240

Cited 0 times in

Cited 0 times in

Updated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC)

DC Field Value Language
dc.date.accessioned2023-06-02T01:17:23Z-
dc.date.available2023-06-02T01:17:23Z-
dc.date.issued2022-09-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194793-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleUpdated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorZ. Qing-
dc.contributor.googleauthorH.R. Kim-
dc.contributor.googleauthorR.A. Soo-
dc.contributor.googleauthorC.H. Chiu-
dc.contributor.googleauthorH. Hayashi-
dc.contributor.googleauthorS-W. Kim-
dc.contributor.googleauthorS. Teraoka-
dc.contributor.googleauthorD-W. Kim-
dc.contributor.googleauthorH. Zhan-
dc.contributor.googleauthorH. Zhao-
dc.contributor.googleauthorH. Li-
dc.contributor.googleauthorT.S.K. Mok-
dc.contributor.googleauthorY-L. Wu-
dc.identifier.doi10.1016/j.annonc.2022.07.1119-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422029702-
dc.citation.volume33-
dc.citation.numberSupplement 7-
dc.citation.startPageS1007-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S1007, 2022-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.